Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (371-380 of 508) with videos related to

Pageof 51
Sort By:
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
European Journal of Anaesthesiology|August 16, 2014
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)Steen Dalby Kristensen, Juhani Knuuti, Antti Saraste, et al.
European Heart Journal|October 6, 2016
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)Thomas M MacDonald, Chris J Hawkey, Ian Ford, et al.
Diabetologia|December 1, 2017
Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohortRoy Taylor, Wilma S Leslie, Alison C Barnes, et al.
Lancet (London, England)|November 30, 2002
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialJames Shepherd, Gerard J Blauw, Michael B Murphy, et al.
European Heart Journal|August 3, 2014
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)Steen Dalby Kristensen, Juhani Knuuti, Antti Saraste, et al.
The Lancet. Diabetes & Endocrinology|March 11, 2019
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trialMichael E J Lean, Wilma S Leslie, Alison C Barnes, et al.
Faraday Discussions|July 5, 2022
Growing crystals by design: general discussionMichael Anderson, Matthew Bennett, Ruel Cedeno, et al.
American Heart Journal|September 2, 2020
Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel diseaseBarbara E Stähli, Ferdinando Varbella, Bettina Schwarz, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
Pageof 51

Showing results (371-380 of 508) with videos related to

Sort By:
Pageof 51
European Heart Journal|March 6, 2024
Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trialJohn G F Cleland, Philip A Kalra, Pierpaolo Pellicori, et al.
European Journal of Anaesthesiology|August 16, 2014
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)Steen Dalby Kristensen, Juhani Knuuti, Antti Saraste, et al.
European Heart Journal|October 6, 2016
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)Thomas M MacDonald, Chris J Hawkey, Ian Ford, et al.
Diabetologia|December 1, 2017
Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohortRoy Taylor, Wilma S Leslie, Alison C Barnes, et al.
Lancet (London, England)|November 30, 2002
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialJames Shepherd, Gerard J Blauw, Michael B Murphy, et al.
European Heart Journal|August 3, 2014
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)Steen Dalby Kristensen, Juhani Knuuti, Antti Saraste, et al.
The Lancet. Diabetes & Endocrinology|March 11, 2019
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trialMichael E J Lean, Wilma S Leslie, Alison C Barnes, et al.
Faraday Discussions|July 5, 2022
Growing crystals by design: general discussionMichael Anderson, Matthew Bennett, Ruel Cedeno, et al.
American Heart Journal|September 2, 2020
Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel diseaseBarbara E Stähli, Ferdinando Varbella, Bettina Schwarz, et al.
Lancet (London, England)|November 8, 2022
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trialPaul R Kalra, John G F Cleland, Mark C Petrie, et al.
Pageof 51